Status:

RECRUITING

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer

Lead Sponsor:

Beijing Chao Yang Hospital

Conditions:

Colorectal Cancer

Neoadjuvant Chemotherapy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Patients with obstruction are associated with worse oncologic outcomes compared with those having nonobstructive tumors. Conventionally, patients with malignant large bowel obstruction receive emergen...

Detailed Description

We hypothesis that, regardless of the MSI state, immunotherapy combined with immediate chemotherapy after stenting may improve overall survival by eradicating micrometastasis. Moreover, immunotherapy ...

Eligibility Criteria

Inclusion

  • Radiologically proven colonic obstruction of the left colon/upper rectum presumed secondary to a carcinoma
  • Able to give written, informed consent
  • Primary tumor was resectable
  • ECOG score 0 or 1
  • Haemoglobin greater than 100 g/L after transfusion before chemotherapy,
  • White blood cells greater than 3.0×10# /L
  • Platelets greater than 100×10# / L;
  • Glomerular filtration rate greater than 50 mL per minute as calculated by the Wright or Cockroft formula
  • Bilirubin less than 1.5×Upper Limit of Normal(ULN)
  • ALT and AST less than 2.5×ULN

Exclusion

  • Distal rectal cancers(equal or less than 10cm from the anal verge)
  • Patients with signs of peritonitis and/or bowel perforation
  • Patients who did not give informed consent
  • Patients who were considered unfit for operative treatment or refuse surgery.
  • Patients with suspected or proven metastatic adenocarcinoma;
  • Patients with unresectable colorectal cancer, or planning for palliative treatment.

Key Trial Info

Start Date :

December 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05202314

Start Date

December 12 2021

End Date

December 30 2026

Last Update

February 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100020